Full Coverage

Serada Half Price Sale: DepoMed's Stock Price Poised to Climb (at Seeking Alpha)

                   
yahoo.com
Nov 8, 2009
 
Story Timeline:  17 days

Serada Half Price Sale: DepoMed's Stock Price Poised to Climb 1 comment by: ThreeBrothersHealth.com November 08, 2009 | about: Several weeks ago, DepoMed (NASDAQ:DEPO), a specialty pharmaceutical company, announced positive... [read full story]                    

powered by
Add Comment
Latest article on this story:

Serada Half Price Sale: DepoMed's Stock Price Poised to Climb

 seekingalpha.com Nov 8, 2009
First article on this story:

Serada Half Price Sale: DepoMed's Stock Price Poised to Climb

 seekingalpha.com Nov 8, 2009
Selected publications with coverage of this story:
yahoo.com seekingalpha.com
RELATED
Found 1 documents:
                   

Serada Half Price Sale: DepoMed's Stock Price Poised to Climb

seekingalpha.com
Nov 8, 2009
 

Three Brothers Health submits: Several weeks ago, DepoMed (NASDAQ: DEPO ), a specialty pharmaceutical company, announced positive phase 3 trial results for the treatment of Post Herpetic Neuralgia (‘PHN’) with DM1796. But...

powered by

Related categories

Health Care, Patients, Seeking Alpha